Where to Buy Tirzepatide: The 2026 Routes and Prices Guide

Search for where to buy tirzepatide and the first page is mostly telehealth pages selling a prescription consultation. That is one route, and not the cheapest. The middle option most of those pages were built around has been closing since March 2025. This page sets out the three routes that exist in September 2026 and what each costs per milligram.

Peptide Bureau links only to research peptide vendors. Nothing here links to a telehealth platform, compounding pharmacy or 503B facility, and none of those routes is recommended. The compounded route is described anyway, because a page about buying tirzepatide that pretends it never existed is not worth reading. Everything below is research use information, not medical advice. For the compound itself see compounded tirzepatide; for insurance and coupons, tirzepatide cost.

The Three Routes a Buyer Actually Has

Three products, three legal frameworks. The price gap between them is mostly a gap in oversight rather than in molecule, which is why comparing them on cost alone is the most common mistake in this category.

Branded Mounjaro and Zepbound, by prescription

Mounjaro is tirzepatide approved for type 2 diabetes, Zepbound the same molecule approved for chronic weight management. This is the only route where someone other than the seller has checked what is in the container: batch release testing, a documented shelf life and a recall mechanism exist here and nowhere else in this guide.

Cost is the obvious problem. A carton holds four single dose pens, one a week, and Lilly's list price is roughly $1,069 per carton. Lilly also sells single dose Zepbound vials through its own direct channel, which when last checked ran $349 to $549 a month depending on dose, plus a savings card capping near $550 where insurance does not cover it.

This is also the honest answer to tirzepatide near me: there is no over the counter retail route. The clinics and medical spas ranking for local intent sell a consultation that may end in a prescription.

The compounded route, and why it has narrowed

Compounded tirzepatide was never an approved product. It existed because tirzepatide went on FDA's drug shortage list during the 2023 and 2024 supply crunch, and that designation widened what compounders could legally prepare. For two years it delivered tirzepatide at $250 to $500 a month against a thousand dollar branded carton, and a telehealth sector grew on the spread.

The spread is closing, and not because of a price change. Mass compounding by 503B outsourcing facilities went outside the rules in March 2025 once supply resolved. FDA then proposed striking semaglutide, tirzepatide and liraglutide from the 503B bulks list entirely; that proposal published 30 April 2026, its comment window closed 29 June 2026, and it now sits with FDA for finalisation. Enforcement has been concrete: ProRx received a warning letter in May 2026 for producing tirzepatide after the shortage ended, and roughly 25 telehealth firms received letters that June. FDA also cites over 1,700 adverse events tied to compounded semaglutide and tirzepatide, with 100 plus hospitalisations and at least ten deaths, mostly dosing errors.

What survives is 503A patient specific compounding, for a documented clinical need the approved product cannot meet. Cost and convenience do not count. That is a conversation with a prescriber, not a storefront you shop, which is why best tirzepatide compounding pharmacy has stopped describing a real decision. The Bureau does not link to or recommend any compounding pharmacy, 503B facility or telehealth platform.

Research grade vials

The third route is a research chemical market. A peptide vendor is not a pharmacy and is not pretending to be one: the product is sold for in vitro laboratory research, the buyer attests to that use, and nothing implies the vial is fit for injection into a person.

Quality control is therefore voluntary. There is no batch release authority and no recall, so a vendor's certificate of analysis is the only evidence of what is in the vial, written by a party with a financial interest in it. The supply chain is also short and shared: most Western vendors buy bulk material from a few contract manufacturers, then aliquot and label, so two vendors with different sites and prices often sell the same batch.

What Changed With the 503B Pathway, and What It Means if You Were Buying Compounded

The 503B bulks list names the ingredients registered outsourcing facilities may compound from at scale. Tirzepatide was never on it; it was compoundable during the shortage under a different provision, and when the shortage resolved that provision went with it. The April 2026 proposal formally excludes it.

So waiting does not help. There is no scheduled reopening, because the basis for the shortage era pathway was a supply problem Lilly has solved. The options are the branded product through a prescriber, a 503A preparation where a prescriber documents that the approved product cannot meet the need, or the research market, which carries a different risk profile and no clinician.

Research Vendor Comparison, With Real Prices

Five vendors in the Bureau's 2026 scorecard carry tirzepatide. These are list prices checked on the dates noted, from the figures that feed the cost per milligram index. They move, so the link shows the live number.

Amino Club and PSPeptides checked 8 September 2026, the others 5 September 2026. The highlighted row is the lowest price per milligram here. Where a vendor sells several sizes this shows one; larger vials are almost always cheaper per milligram.

The vial ladder, because vial price is not comparable

Tirzepatide is sold in 5mg, 10mg, 15mg, 20mg, 30mg and 60mg presentations. Comparing vial prices across vendors compares different quantities of material, which is how a reader concludes the expensive vendor is cheap. The only comparable figure is dollars per milligram.

Apollo and Pantheon checked 5 September 2026, PSPeptides 8 September 2026. The large vial saving is real only if the material survives the months it takes to use, which is a storage question.

What each vendor is good for

Amino Club leads on cost per milligram at $2.00 on its 30mg presentation, the lowest in the index. It lists tirzepatide as GLP-2, so a catalogue search for the drug name returns nothing, and gates entry behind a researcher verification step. See the Amino Club review and the GLP-2 listing.

PSPeptides is the only vendor in the scorecard shipping outside the United States, reaching Canada, the EU, the UK and Australia. Its 60mg vial at $199.99 is $3.33 per mg, second lowest here. Code PEPTIDEBUREAU takes 10 percent off and still counts the order. Tirzepatide listing here.

Apollo Peptide Sciences runs the most consistent GLP coding of the group, listing semaglutide as GLP-1 S, tirzepatide as GLP-2 T and retatrutide as GLP-3 R, so all three price against one another on one site. Per lot certificates are published, and it runs the deepest vial ladder. One caveat: Apollo leans hardest into GLP analogues, the class drawing the most regulatory attention, which the Apollo review flags. GLP-2 T listing here.

Pantheon Peptides is the dearest per milligram here and the widest catalogue of the five, so it suits a protocol needing several compounds in one shipment: review and product page. Ascension Peptides and Limitless Life are worth a price check on a large order, and both route to a storefront rather than a product page. Ascension's listing did not publish a vial size, so no per milligram figure is computed for it. Ascension storefront, Limitless storefront, Ascension review.

How to Judge a Vendor

Ordered by how much money each check saves. First is a lot matched certificate of analysis: not a certificate, the certificate carrying the lot number printed on the vial you will be shipped. A generic PDF on a product page can describe a batch from eighteen months ago that has restocked six times since. Ask by email for the lot currently shipping.

Second is reading that certificate, because most buyers look at the purity number and stop, and purity is the least informative line on the page.

Lyophilised powder is typically 70 to 90 percent peptide by mass, so label weight and peptide weight differ. The peptide testing guide covers independent testing on your own vial, roughly forty to a hundred dollars over one to three weeks.

Third is shipping. Domestic dispatch arrives in two to four days and crosses no border. International shipping is cheaper, slower, and carries a seizure risk landing on the buyer unless the vendor has a written reship policy. Cold chain is largely theatre for lyophilised powder; temperature matters after reconstitution.

Fourth is payment, your only recourse. Cards carry chargeback rights; bank transfer, crypto and payment app transfers carry none. Many vendors have lost card processing and offer crypto at around ten percent off, which is a real discount and a real transfer of risk. On a first order, the card premium buys the ability to reverse a bad transaction.

Cost Per Milligram Across All Three Routes

This is the table the page exists to produce, with a caveat that matters more than the numbers. These routes do not sell the same thing: the branded rows buy an approved product with batch release testing and a recall mechanism, the research row a research chemical with a voluntary certificate. One table compares price, not value.

Read the spread rather than any single row. Within the approved routes, the difference between a cash carton and the manufacturer's own direct vials is a factor of two to three, the largest saving available without changing what is bought. The research market sits an order of magnitude lower again, and that gap is what a buyer is weighing. The cost per milligram index runs the same arithmetic across eighteen compounds.

Red Flags and How to Spot a Fake Vendor

These correlate with something going wrong on a tirzepatide order specifically, because it is an expensive, heavily counterfeited, 39 residue peptide with a real synthesis cost floor.

• A certificate with no lot number, or one that does not match the vial. The highest yield check available, and it costs one email.
• Purity stated to three decimal places. HPLC does not resolve that finely. A report reading 99.876 percent is a design choice, not a measurement.
• No testing laboratory named. A blank lab field means the vendor tested its own product.
• A price far below the market. A vial at a third of the going rate is either a bulk position someone is unwinding or a vial that does not contain what the label says.
• Human dosing language on a research page. A vendor writing titration schedules beside a research use only disclaimer has not understood its own legal position, and FDA is reported to be scraping for that contradiction.
• No stated reship or refund position. On international shipping this is the difference between a delayed order and a lost one.
• A domain closely resembling a known vendor. Cloned storefronts are an active problem here.

The full method is in how to spot a fake peptide vendor. If tirzepatide is not the only compound you are pricing, where to buy retatrutide runs the same analysis on the triple agonist, where the legal position is more restrictive again.

Storage and Reconstitution Basics

Before reconstitution, lyophilised tirzepatide is kept frozen, typically near minus 20 degrees Celsius and protected from light, and it holds that way for a long time, which is what makes the large vial discount real. After reconstitution the clock starts: the figure in circulation is 28 days refrigerated at 2 to 8 degrees Celsius.

The arithmetic is the other half. Concentration is vial milligrams divided by millilitres of bacteriostatic water added, and marks on a U-100 syringe are the resulting volume in millilitres times 100. Concentrated mixtures are where errors live: at 10 mg/mL a small amount sits on a handful of marks, so a one mark misread is a large proportional error, the mechanism behind most of the compounded GLP-1 adverse events FDA cites. Diluting further moves the same quantity into a range where that misread costs far less. Any combination can be checked against the tirzepatide dosage calculator, with mixing in how to reconstitute peptides, stability in the storage guide and diluent choice in the bacteriostatic water guide. Both PSPeptides and Amino Club carry bacteriostatic water, which saves a second shipment.

Key Takeaways

• Three routes: branded by prescription, compounded through a prescriber, and research grade vials sold for laboratory use only
• The compounded route has narrowed, not paused, and the exclusion proposal's comment window closed on 29 June 2026
• Tirzepatide near me has no retail answer. Local results are consultations that may end in a prescription
• Research vendor prices run $2.00 to $15.00 per mg against roughly $26.70 for a cash Mounjaro carton, and that gap is mostly the price of oversight
• Vial price is not comparable across vendors. Larger vials run 14 to 41 percent cheaper per mg at the same vendor
• Purity is a ratio and says nothing about quantity, which is where underfilling hides
• Card payment on a first order buys chargeback rights that crypto does not

Once a source is settled, the tirzepatide dosage guide covers escalation schedules and unit conversions, microdosing tirzepatide covers the low dose pattern, and semaglutide vs tirzepatide covers whether the second receptor is worth the extra side effect load.

Frequently Asked Questions

Where can you actually buy tirzepatide in 2026?

Three routes, and they are not equivalent. Branded Mounjaro or Zepbound comes from a pharmacy against a prescription and is the only one producing an FDA approved finished drug product. Compounded tirzepatide came from 503A and 503B pharmacies during the shortage and has narrowed to patient specific compounding for a documented clinical need. Research grade tirzepatide is sold by peptide vendors for laboratory use only, with no approval and no pharmacy oversight.

What is the cheapest way to get tirzepatide without insurance?

On cost per milligram the research vendor market is cheapest by a wide margin, roughly two to fifteen dollars per milligram against about twenty seven for a cash Mounjaro carton at list price. Within the approved routes, Eli Lilly's single dose Zepbound vials through its own direct channel were the lowest published cash option, roughly 349 to 549 dollars a month when last checked. Those are prices for an approved product; the research figure is for a research chemical.

Why is tirzepatide sold as GLP-2 by some vendors?

Naming an on patent drug on a public product page draws attention from the trademark holder and from payment processors, either of which can close a store faster than a regulator can. GLP-2, GLP-2 T and TIRZ are the same molecule under a name that avoids that exposure, exactly as retatrutide is listed as GLP-3. It is a commercial defence, not a chemical distinction, and the certificate of analysis confirms what the code resolves to.

Is there a best tirzepatide compounding pharmacy?

The regulation has overtaken the question. Mass compounding by 503B outsourcing facilities has been outside the rules since March 2025, FDA's proposal to strike tirzepatide from the 503B bulks list closed its comment window on 29 June 2026, and enforcement has been active. What survives is 503A patient specific compounding for a documented clinical need, which is a conversation with a prescriber. Peptide Bureau does not link to or recommend any compounding pharmacy, 503B facility or telehealth platform.

How do you tell a real tirzepatide vendor from a fake one?

Ask for the certificate carrying the lot number printed on the vial you will be shipped, not the generic file on the product page. A real report names the testing laboratory, gives HPLC purity to one decimal place rather than three, and includes a mass spectrometry identity near 4,813 daltons. Purity says nothing about how much peptide is in the vial, so a quantitative assay is the only direct evidence against underfilling.